These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 28370369

  • 1. Independent adjudicator assessments of platelet refractoriness and rFVIIa efficacy in bleeding episodes and surgeries from the multinational Glanzmann's thrombasthenia registry.
    Recht M, Rajpurkar M, Chitlur M, d'Oiron R, Zotz R, Di Minno G, Cooper DL, Poon MC.
    Am J Hematol; 2017 Jul; 92(7):646-652. PubMed ID: 28370369
    [Abstract] [Full Text] [Related]

  • 2. The international, prospective Glanzmann Thrombasthenia Registry: treatment and outcomes in surgical intervention.
    Poon MC, d'Oiron R, Zotz RB, Bindslev N, Di Minno MN, Di Minno G, Glanzmann Thrombasthenia Registry Investigators.
    Haematologica; 2015 Aug; 100(8):1038-44. PubMed ID: 26001792
    [Abstract] [Full Text] [Related]

  • 3. The Use of Recombinant Activated Factor VII in Patients with Glanzmann's Thrombasthenia.
    Poon MC.
    Thromb Haemost; 2021 Mar; 121(3):332-340. PubMed ID: 33124022
    [Abstract] [Full Text] [Related]

  • 4. New Insights Into the Treatment of Glanzmann Thrombasthenia.
    Poon MC, Di Minno G, d'Oiron R, Zotz R.
    Transfus Med Rev; 2016 Apr; 30(2):92-9. PubMed ID: 26968829
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Use of recombinant activated factor VII in patients with Glanzmann's thrombasthenia: a review of the literature.
    Rajpurkar M, Chitlur M, Recht M, Cooper DL.
    Haemophilia; 2014 Jul; 20(4):464-71. PubMed ID: 24948404
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. NovoSeven (recombinant factor VIIa) for the treatment of bleeding episodes and perioperative management in patients with Glanzmann's thrombasthenia.
    Franchini M, Lippi G.
    Expert Rev Hematol; 2014 Dec; 7(6):733-40. PubMed ID: 25387838
    [Abstract] [Full Text] [Related]

  • 10. Eptacog alfa activated: a recombinant product to treat rare congenital bleeding disorders.
    Di Minno G.
    Blood Rev; 2015 Jun; 29 Suppl 1():S26-33. PubMed ID: 26073366
    [Abstract] [Full Text] [Related]

  • 11. Perioperative management of a pediatric patient with Glanzmann's thrombasthenia during adenoidectomy.
    Duman EN, Saylan S, Cekic B.
    Rev Bras Anestesiol; 2012 Jul; 62(4):548-53. PubMed ID: 22793971
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Control of severe bleeding episode in case of Glanzmann's thrombasthenia refractory to platelet transfusion therapy by administering recombinant factor VIIa.
    Javed A, Ayyub M, Abrar S, Mansoor M, Khan B, Hussain T.
    J Ayub Med Coll Abbottabad; 2009 Jul; 21(2):171-3. PubMed ID: 20524499
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Perioperative administration of recombinant activated factor VII in a Glanzmann's thrombasthenia patient with platelet refractoriness: case report.
    Bisinotto FMB, Martins LB, de Camargos GP, Bianco MP.
    Braz J Anesthesiol; 2022 Jul; 72(6):823-825. PubMed ID: 34852265
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Glanzmann's thrombasthenia (defective platelet integrin alphaIIb-beta3): proposals for management between evidence and open issues.
    Di Minno G, Coppola A, Di Minno MN, Poon MC.
    Thromb Haemost; 2009 Dec; 102(6):1157-64. PubMed ID: 19967146
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.